Literature DB >> 27377225

Functional Hemispherectomy for Refractory Status Epilepticus in 2 Adults.

Michael McGinity1, Nicholas Andrade2, Kameel Karkar3, Jean-Louis Caron4, Charles Szabó5, Alexander Papanastassiou4.   

Abstract

BACKGROUND: Status epilepticus (SE) is a medical emergency, as deleterious long-term effects are well known. Medically induced burst suppression is often required if first-line and second-line treatments fail. Surgical intervention can be considered in some patients after prolonged treatment failure of medically induced coma. Multiple surgical options for terminating SE have been demonstrated in the literature, with only 2 reports including hemispherectomy in adults. CASE DESCRIPTION: We present 2 cases of adults with refractory SE who failed more conservative medical/surgical treatment but responded to functional hemispherectomy. Pertinent electroencephalography and imaging findings are discussed. In addition, all previously published pediatric and adult cases are briefly reviewed.
CONCLUSIONS: Functional hemispherectomy can be considered in patients, including adults, with super-refractory SE and diffuse hemispheric onset. We report acceptable outcomes and quality of life in our 2 patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EEG; Epilepsy; Hemispherectomy; Neurosurgery; Seizure; Status epilepticus

Mesh:

Year:  2016        PMID: 27377225     DOI: 10.1016/j.wneu.2016.06.086

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  Hemispherotomy for late post-traumatic super-refractory status epilepticus in an adult.

Authors:  Raghavendra Nayak; Vivek Mathew; Ramanan Rajgopal; Krishnaprabhu Raju
Journal:  Epilepsy Behav Case Rep       Date:  2017-09-18

2.  Adult-onset Rasmussen's Syndrome with associated cortical dysplasia.

Authors:  C Ákos Szabó; Rachel Garvin; Shaheryar Hafeez; Ali Seifi; Linda Leary; Ratna Bhavaraju-Sanka; James M Henry; Alex M Papanastassiou
Journal:  Epilepsy Behav Case Rep       Date:  2018-11-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.